
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Annexin V CRISPR/Cas9 KO Plasmid (m) | sc-419117 | 20 µg | $397.00 |
Mouse Anxa5 encodes annexin V, a Ca²⁺-dependent phospholipid-binding protein that associates with the inner leaflet of cellular membranes and is rapidly recruited to sites of membrane remodeling. Annexin V contributes to membrane repair, vesicle trafficking, and regulation of cytoskeletal dynamics, and is widely used as a molecular marker for phosphatidylserine exposure during apoptosis. Through its interactions with anionic phospholipids, annexin V influences calcium signaling–linked processes and can modulate inflammatory and coagulation-relevant membrane events. Altered ANXA5 expression or localization has been associated with dysregulated cell death responses and tissue injury contexts, supporting its study in models of immune activation, cardiovascular biology, and cancer cell stress.
Annexin V CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Anxa5 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Anxa5 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Anxa5 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Annexin V protein expression.
This CRISPR knockout system enables efficient generation of Anxa5-deficient cell models for investigation of Annexin V signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.